Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1972 3
1973 1
1974 3
1977 2
1979 1
1980 2
1982 1
1986 1
1987 1
1988 4
1989 1
1990 1
1991 4
1992 2
1993 3
1994 3
1995 7
1996 4
1997 9
1998 6
1999 10
2000 9
2001 11
2002 13
2003 3
2004 6
2005 12
2006 11
2007 14
2008 6
2009 6
2010 12
2011 7
2012 12
2013 11
2014 5
2015 7
2016 6
2017 6
2018 3
2019 8
2020 8
Text availability
Article attribute
Article type
Publication date

Search Results

220 results
Results by year
Filters applied: . Clear all
Page 1
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
Pertwee RG. Pertwee RG. Br J Pharmacol. 2008 Jan;153(2):199-215. doi: 10.1038/sj.bjp.0707442. Epub 2007 Sep 10. Br J Pharmacol. 2008. PMID: 17828291 Free PMC article. Review.
Endocannabinoids and Their Pharmacological Actions.
Pertwee RG. Pertwee RG. Handb Exp Pharmacol. 2015;231:1-37. doi: 10.1007/978-3-319-20825-1_1. Handb Exp Pharmacol. 2015. PMID: 26408156 Review.
Early phytocannabinoid chemistry to endocannabinoids and beyond.
Mechoulam R, Hanuš LO, Pertwee R, Howlett AC. Mechoulam R, et al. Among authors: pertwee r. Nat Rev Neurosci. 2014 Nov;15(11):757-64. doi: 10.1038/nrn3811. Epub 2014 Oct 15. Nat Rev Neurosci. 2014. PMID: 25315390 Review.
Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.
McPartland JM, Duncan M, Di Marzo V, Pertwee RG. McPartland JM, et al. Among authors: pertwee rg. Br J Pharmacol. 2015 Feb;172(3):737-53. doi: 10.1111/bph.12944. Br J Pharmacol. 2015. PMID: 25257544 Free PMC article. Review.
Pharmacology of cannabinoid CB1 and CB2 receptors.
Pertwee RG. Pertwee RG. Pharmacol Ther. 1997;74(2):129-80. doi: 10.1016/s0163-7258(97)82001-3. Pharmacol Ther. 1997. PMID: 9336020 Review.
Isolation and structure of a brain constituent that binds to the cannabinoid receptor.
Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R. Devane WA, et al. Among authors: pertwee rg. Science. 1992 Dec 18;258(5090):1946-9. doi: 10.1126/science.1470919. Science. 1992. PMID: 1470919
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors.
Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG. Howlett AC, et al. Among authors: pertwee rg. Pharmacol Rev. 2002 Jun;54(2):161-202. doi: 10.1124/pr.54.2.161. Pharmacol Rev. 2002. PMID: 12037135 Review.
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities.
Pertwee RG. Pertwee RG. Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3353-63. doi: 10.1098/rstb.2011.0381. Philos Trans R Soc Lond B Biol Sci. 2012. PMID: 23108552 Free PMC article. Review.
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.
Pertwee RG, Howlett AC, Abood ME, Alexander SP, Di Marzo V, Elphick MR, Greasley PJ, Hansen HS, Kunos G, Mackie K, Mechoulam R, Ross RA. Pertwee RG, et al. Pharmacol Rev. 2010 Dec;62(4):588-631. doi: 10.1124/pr.110.003004. Pharmacol Rev. 2010. PMID: 21079038 Free PMC article. Review.
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
Fernández-Ruiz J, Sagredo O, Pazos MR, García C, Pertwee R, Mechoulam R, Martínez-Orgado J. Fernández-Ruiz J, et al. Among authors: pertwee r. Br J Clin Pharmacol. 2013 Feb;75(2):323-33. doi: 10.1111/j.1365-2125.2012.04341.x. Br J Clin Pharmacol. 2013. PMID: 22625422 Free PMC article. Review.
220 results
Jump to page
Feedback